[The influence of perindopril on intrarenal RAS in experimental diabetic rats].
OBJECTIVE
To examine the effect of perindopril on the intrarenal renin angiotensin system (RAS) in diabetic rats.


METHODS
Diabetes of rats was induced by a single injection of STZ. The rats were treated with perindopril (1 mg.kg-1.d-1) and the controls were given insulin only. Plasma and intrarenal renin activity (PRA, TRA) and angiotensin I (PAT I, TATII) were measured by radioimmunoassay in the diabetic rats at 1, 3, 6 months. Message RNA (mRNA) expression of renal angiotensinogen (TATO) and TATII receptor (TATII R) was assessed by slot blot hybridization.


RESULTS
At 6 month, TATII levels in the control group were significantly decreased compared with those of normal controls (P < 0.05), and TATII levels in perindopril treated rats were decreased remarkedly compared with those of the control group (P < 0.01). TRA was not different among the three groups at 3 to 6 months (P > 0.05). In slot blot hybridization TATII R mRNA expression in the control group was markedly increased compared with that of perindopril treated and normal control groups (P < 0.05, P < 0.01). TATO mRNA expression was not different among the three groups (P > 0.05) during the experimental period.


CONCLUSIONS
The abnormalities of intrarenal RAS existed in STZ induced diabetic rats, including the decrement of TATII content and the enhancement of TATII R mRNA expression. Perindopril could further decrease the level of intrarenal TATII, and inhibit its receptor mRNA expression.
Liu
Y
Y
Department of Endocrinology, General Hospital of PLA, Beijing.
Pan
C
C
Lu
J
J
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000808:Angiotensinogen / Q000096:biosynthesis / Q000235:genetics; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D007211:Indoles / Q000494:pharmacology*; D007668:Kidney / Q000378:metabolism*; D008297:Male; D020913:Perindopril; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D012084:Renin-Angiotensin System / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; D012333:RNA, Messenger; D000808:Angiotensinogen; D020913:Perindopril